Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Endpoints News presents its annual (and once again virtual) R&D Summit: June 14-16

PR Newswire June 1, 2021

CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis

PR Newswire June 1, 2021

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

PR Newswire June 1, 2021

Israeli Femtech Start-up, Ark Surgical, secures $2.1 Million in Funding for LapBox Tissue Containment System for Laparoscopic GYN Surgery

PR Newswire June 1, 2021

VOTIS Subdermal Imaging Technologies Raises US$2.5 Million

PR Newswire June 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results

PR Newswire June 1, 2021

Sutro Biopharma Earns Milestone Payment from Bispecific Antibody-Drug Conjugate Collaboration with Merck KGaA, Darmstadt, Germany

PR Newswire June 1, 2021

Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer

PR Newswire June 1, 2021

Alkermes Announces FDA Approval of LYBALVI(TM) for the Treatment of Schizophrenia and Bipolar I Disorder

PR Newswire June 1, 2021

Compugen Management to Discuss COM701 Data Presented at ASCO at Event Hosted by Truist Securities

PR Newswire June 1, 2021

Quebec extends public reimbursement of DUPIXENT® (dupilumab injection) for the treatment of moderate-to-severe atopic dermatitis to include adolescents

Canada NewsWire June 1, 2021

Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month

Canada NewsWire June 1, 2021

Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing

PR Newswire June 1, 2021

LifeStance Health Group, Inc. Announces Launch of Initial Public Offering

PR Newswire June 1, 2021

ACON Investments Acquires Vitalis Group

PR Newswire June 1, 2021

New Study Using Machine Learning Shows Promise in Predicting Birth Defects Cases

PR Newswire June 1, 2021

Immunic, Inc. Announces Appointment of Inderpal Singh as General Counsel

PR Newswire June 1, 2021

NRx Pharmaceuticals Announces Positive Results for ZYESAMI(TM) (Aviptadil-acetate) and Submits Emergency Use Authorization Application to US Food and Drug Administration to Treat Critical COVID-19 in Patients Suffering from Respiratory Failure

PR Newswire June 1, 2021

NovaBiotics Announces Publication of Data Elucidating NP339's Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy

PR Newswire June 1, 2021

Positive FDA meetings enable Neuren to proceed with INDs for three Phase 2 trials

PR Newswire June 1, 2021